UNCLAIMED
Fabric Genomics
Overview
Fabric Genomics is a company based in the United States that operates within the business services sector, specifically focusing on research and development in the biotech and pharmaceuticals industries. Founded in 2009, the company employs between 11 and 50 individuals and has reported revenue of approximately 8.67 million USD. Its expertise lies in genomic testing, particularly in the context of neonatal care and the diagnosis of genetic disorders. A recent research article highlights the company's involvement in the Genomic Medicine for Ill Neonates and Infants (GEMINI) study, which compared whole-genomic sequencing with a targeted neonatal gene-sequencing test in hospitalized infants suspected of having genetic disorders. This study involved 400 infants and assessed the impact of genomic testing on clinical management and health outcomes. The methodology included the use of advanced sequencing techniques and clinical software for variant identification and reporting. Fabric Genomics thus contributes to the field of genomics by facilitating improved diagnostic capabilities and informing medical decisions in early life.